Uganda mobilises diagnostics supplies and labs support in response to fever outbreak:
This article was originally published in Clinica
The Ugandan government is mobilising diagnostic testing and laboratory resources to stem an outbreak of Marburg haemorrhagic fever (MHF). The ministry of health (MoH) is acting to monitor and halt a possible spread of the infection beyond a single group of several cases, including one fatality, reported over the last month, according to a statement issued today by the World Health Organisation. The WHO is supporting the MoH with supplies and logistics efforts. The laboratory investigations are being carried out by the Uganda Virology Research Institute and the Kenya Medical Research Institute, backed by the Atlanta, US laboratory of the Centers for Disease Control and Prevention (CDC), where the definitive confirmation of MHF was made.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.